Cardio Diagnostics Holdings, Inc.
CDIO- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001870144
No open-market purchases or sales by Cardio Diagnostics Holdings, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $422.7K in total; no superinvestor holds it.
Other share classesCDIOW
Q4 2022 vs. Q3 2022
How the institutions holding Cardio Diagnostics Holdings, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 0 | 12 | +12 |
| Shares | 0 | 228.8K | +228.8K |
| Value | $0 | $248.8K | +$248.8K |
New holders (12)
Institutions that held Cardio Diagnostics Holdings, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Linden Advisors LP | 85,713 | $95.1K | 0.00% |
| Polar Asset Management Partners Inc. | 25,698 | $27.2K | 0.00% |
| Susquehanna International Group, LLP | 23,646 | $26.2K | 0.00% |
| D. E. Shaw & Co., Inc. | 20,077 | $22.3K | 0.00% |
| Yakira Capital Management, Inc. | 20,757 | $22.0K | 0.00% |
| Context Capital Management, LLC | 16,278 | $17.0K | 0.00% |
| Boothbay Fund Management, LLC | 13,572 | $14.4K | 0.00% |
| Atw Spac Management LLC | 13,572 | $14.4K | 0.00% |
| Caldwell Sutter Capital, Inc. | 8,101 | $8.59K | 0.01% |
| UBS Group AG | 1,384 | $1.47K | 0.00% |
| Wells Fargo & Company | 41 | $43 | 0.00% |
| Morgan Stanley | 3 | $3 | 0.00% |
Sold out (0)
Institutions that held Cardio Diagnostics Holdings, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
None.